Schedule 13D ownership disclosure

MARKER THERAPEUTICS ORD

Security class unavailable · CUSIP: 57055L107

Event date: 2018-10-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-18-303199
Form type
SC 13D
Filer
Aisling Capital IV, LP
CIK
CIK 1652910
Filed
Oct 19, 2018
Reporting period
Oct 17, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub